Juniper Investment Company LLC Increases Stock Holdings in Orthofix Medical Inc. $OFIX

Juniper Investment Company LLC lifted its stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX) by 23.3% during the fourth quarter, HoldingsChannel reports. The firm owned 3,510,333 shares of the medical device company’s stock after acquiring an additional 663,278 shares during the quarter. Orthofix Medical makes up 18.3% of Juniper Investment Company LLC’s investment portfolio, making the stock its 3rd largest position. Juniper Investment Company LLC owned approximately 0.09% of Orthofix Medical worth $53,217,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Kestra Advisory Services LLC bought a new stake in shares of Orthofix Medical during the 4th quarter worth approximately $56,000. CWM LLC raised its stake in shares of Orthofix Medical by 136.4% during the 4th quarter. CWM LLC now owns 4,538 shares of the medical device company’s stock worth $69,000 after purchasing an additional 2,618 shares in the last quarter. Strs Ohio bought a new stake in shares of Orthofix Medical during the 1st quarter worth approximately $150,000. Mackenzie Financial Corp bought a new stake in shares of Orthofix Medical during the 3rd quarter worth approximately $148,000. Finally, Diversified Trust Co. bought a new stake in shares of Orthofix Medical during the 4th quarter worth approximately $159,000. Institutional investors own 89.76% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. TD Cowen reiterated a “hold” rating on shares of Orthofix Medical in a research note on Thursday, May 21st. Canaccord Genuity Group dropped their price objective on Orthofix Medical from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Thursday, May 21st. Weiss Ratings reiterated a “sell (d-)” rating on shares of Orthofix Medical in a research note on Tuesday, April 21st. Stifel Nicolaus dropped their price objective on Orthofix Medical from $18.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, May 22nd. Finally, Wall Street Zen cut Orthofix Medical from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Three equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Orthofix Medical presently has a consensus rating of “Hold” and an average price target of $15.50.

Insider Transactions at Orthofix Medical

In other Orthofix Medical news, Director John B. Henneman III bought 5,000 shares of Orthofix Medical stock in a transaction dated Thursday, May 7th. The stock was bought at an average cost of $12.26 per share, for a total transaction of $61,300.00. Following the purchase, the director owned 90,809 shares of the company’s stock, valued at $1,113,318.34. The trade was a 5.83% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder Engine Capital Management, Lp bought 112,950 shares of Orthofix Medical stock in a transaction dated Tuesday, May 5th. The shares were acquired at an average price of $11.99 per share, with a total value of $1,354,270.50. Following the completion of the purchase, the insider directly owned 3,783,131 shares in the company, valued at $45,359,740.69. This trade represents a 3.08% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders acquired 189,896 shares of company stock worth $2,293,970. 2.70% of the stock is owned by company insiders.

Orthofix Medical Stock Performance

Shares of NASDAQ OFIX opened at $9.23 on Thursday. The company has a current ratio of 2.87, a quick ratio of 1.76 and a debt-to-equity ratio of 0.54. Orthofix Medical Inc. has a 12 month low of $9.12 and a 12 month high of $16.99. The stock has a 50 day moving average of $11.22 and a 200-day moving average of $12.88. The company has a market capitalization of $373.08 million, a P/E ratio of -6.11 and a beta of 0.71.

Orthofix Medical (NASDAQ:OFIX) last issued its earnings results on Tuesday, May 5th. The medical device company reported ($0.52) EPS for the quarter, topping the consensus estimate of ($0.68) by $0.16. Orthofix Medical had a negative return on equity of 13.44% and a negative net margin of 7.27%.The company had revenue of $196.71 million during the quarter, compared to the consensus estimate of $196.40 million. As a group, equities research analysts predict that Orthofix Medical Inc. will post -1.48 EPS for the current year.

Orthofix Medical Company Profile

Orthofix Medical Inc (NASDAQ: OFIX) is a global medical device company focused on the design and development of innovative orthopedic and spinal solutions. The company’s core business is divided into two segments: spine and orthopedics. In the spine segment, Orthofix offers a range of titanium implants, biologics and portable bone growth stimulation devices designed to support spinal fusion, deformity correction and minimally invasive procedures. Its orthopedic segment encompasses products for fracture fixation, external fixation systems, trauma care and sports medicine, providing surgeons with implantable devices and instruments for complex bone reconstruction and healing.

Orthofix’s product portfolio includes strut systems, bone growth stimulators, interbody fusion devices and fixation hardware that address various indications such as degenerative disc disease, spinal deformities, non-unions and long-bone fractures.